Search results for "Aflatoxin B1"

showing 2 items of 32 documents

Epidemiology, Risk Factors, and Natural History of Hepatocellular Carcinoma

2002

The incidence of hepatocellular carcinoma is increasing in many countries. The estimated number of new cases annually is over 500,000, and the yearly incidence comprises between 2.5 and 7% of patients with liver cirrhosis. The incidence varies between different geographic areas, being higher in developing areas; males are predominantly affected, with a 2:3 male/female ratio. The heterogeneous geographic distribution reflects the epidemiologic impact of the main etiologic factors and environmental risk, which are the hepatitis B (HBV) and hepatitis C (HCV) viruses. The percentage of cases of hepatocellular carcinoma attributable to HBV worldwide is 52.3% and is higher in Asia where the serop…

Viral Hepatitis VaccinesHepatitis B virusmedicine.medical_specialtyAflatoxin B1Carcinoma HepatocellularCirrhosisPopulationHepacivirusmedicine.disease_causeGastroenterologyGeneral Biochemistry Genetics and Molecular BiologyHistory and Philosophy of ScienceRisk FactorsInternal medicinemedicineCarcinomaHumanseducationHepatitis B viruseducation.field_of_studybusiness.industryGeneral NeuroscienceIncidence (epidemiology)Liver NeoplasmsHepatitis CHepatitis BHepatitis Bmedicine.diseaseHepatitis Cdigestive system diseasesAlcoholsHepatocellular carcinomabusinessAnnals of the New York Academy of Sciences
researchProduct

Bioaccessibility Study of Aflatoxin B1 and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin

2021

The presence of mycotoxins in cereals and cereal products remains a significant issue. The use of natural ingredients such as pumpkin and whey, which contain bioactive compounds, could be a strategy to reduce the use of conventional chemical preservatives. The aim of the present work was to study the bioaccessibility of aflatoxin B1 (AFB1) and ochratoxin (OTA) in bread, as well as to evaluate the effect of milk whey (with and without lactic acid bacteria fermentation) and pumpkin on reducing mycotoxins bioaccessibility. Different bread typologies were prepared and subjected to an in vitro digestion model. Gastric and intestinal extracts were analyzed by HPLC–MS/qTOF and mycotoxins bio…

animal structuresHealth Toxicology and Mutagenesisdigestive oral and skin physiologybreadwheyRfood and beveragesToxicologyBacterisbioaccessibilityCompostos orgànics Síntesifluids and secretionsaflatoxin B1pumpkinMedicinebioaccessibility; aflatoxin B1; ochratoxin A; bread; pumpkin; whey; lactic acid bacteriaochratoxin AProductes químics Efectes fisiològicsToxins; Volume 14; Issue 1; Pages: 6
researchProduct